Restricted Marketable Securities

12 Months Ended

Dec. 31, 2013

Investments Debt And Equity Securities [Abstract]

Restricted Marketable Securities

2. Restricted Marketable Securities

Pursuant to the terms of the Amended and Restated License Agreement with Harvard University and its affiliated hospitals (Harvard) entered into on July 31, 2012, at December 31, 2013 and 2012 respectively, the Company had an obligation to transfer 5,000 and 15,000 shares of the Navidea stock to Harvard. The market value of the shares on December 31, 2013 and 2012 respectively was $10,350 and $42,450. The 5,000 shares of NAVB common stock held by the Company at December 31, 2013 is classified as restricted securities in the consolidated balance sheet and the corresponding liability is reported in other current liabilities. The Company completed the transfer of the 15,000 shares of NAVB in January 2013.